![Graphics 13 February.](https://www.uio.no/english/research/strategic-research-areas/life-science/norway-life-science-conference/norway-life-science-2023/images/nettbanner_program_13_feb_1200x400_eng.png)
09:30–10:40 Setting the stage for Norway Life Science 2023
Speakers
- Svein Stølen, Rector, University of Oslo
- Raymond Johansen, Governing Mayor of Oslo
- Jan Christian Vestre, Minister of Trade and Industry
Facilitating research-based innovation
A dialogue with
- Oline Marie Sæther, President, Student Parliament
- Hilde Nebb, Innovation director and Professor, UiO Growth House
- Agnete Fredriksen, Chief Business Officer & Co-founder, Nykode Therapeutics
The Norwegian knowledge-base
A dialogue with
- Bjørn Atle Bjørnbeth, CEO, Oslo University Hospital
- Leif Rune Skymoen, Newly appointed General Manager LMI
- Arnoldo Frigessi, Professor, Department of Biostatistics, UiO
Chair: Carl Henrik Gørbitz, Director, UiO:Life Science
Photo Vestre: NTB/SMK.
10:40–11:00 Break
11:00–12:00 Parallel Sessions
Enabling technologies in future health care
- Stefan Krauss, Centre director, Professor, Hybrid Technology Hub, UiO
The organoid revolution in biomedical research
- Sven Even Borgos, Senior Research Scientist, SINTEF
Nanoformulated mRNA therapeutics are changing medicine. Vaccines - and beyond!
- Tor Sverre Lande, Professor Dept. of Informatics
- Dag Wisland, Professor, Research Group for Nanoelectronic systems, UiO
From Science to Sensors – Emerging Biosensing Technology
- Cathrine Ro Heuch CEO and co-founder, Nordic Brain Tech
Innovation in digital migraine treatment
Chair: Hanne Mette Dyrlie Kristensen, CEO, The Life Science Cluster
Artificial intelligence in diagnostics and treatments
- Ingrid Glad, Professor, Statistics and Data Science, UiO
Integreat: The Norwegian Center for Knowledge-Driven Machine Learning
- Victor Greiff, Associate Professor, Dep of Immunology, UiO
AI-based mining of adaptive immunity for in silico diagnostics and therapeutics design
- Kjell-Inge Gjesdal CEO NordicCAD
Deep Learning based anatomical segmentation and 3D visualization of medical images
- Bjørnar Grenne, Consultant Cardiologist and Researcher, NTNU/St. Olavs Hospital
- Andreas Østvik, Research Scientist, SINTEF
Artificial intelligence in heart ultrasound for improved patient care
Chair: Morten Dalsmo, Executive Vice President, SINTEF Digital
Private-public partnerships: Pitfalls and opportunities
Can new collaborative models contribute to finding good and cost-effective solutions to health problems?
- Åslaug Helland, Professor and Oncologist, UiO and Oslo University Hospital
- Eli Bergli, Healthcare Partnership Director, Novartis Norway
How can public-private partnerships improve access to innovation and improve healthcare - Kristina Haugaa, Center director, ProCardio Center for Innovation, Oslo University Hospital
- Eigil Samset, Leader, GE HealthCare
40 years of successful collaboration and innovation between a world leading med tech company and Norway's leading cardiology clinic
- Martin Fredriksen, COO Nordics, Dignio
-
Hilde Terese Hamre, Director, Health care administration (Helseetaten), City of Oslo
Remote patient monitoring of Covid-19 patients. Public-private partnership in a crisis
Chair: Ketil Widerberg, General Manager, Oslo Cancer Cluster
12:00–13:00 Lunch
13:00-14:10 New Norwegian health industry - prerequisites for success
Speakers
-
Helge Lund, Chairman of the board, Novo Nordisk
-
Gustav Gotteberg, Managing Director & Senior Partner, Boston Consulting Group Oslo
-
Ole Erik Almlid, Director General of the Confederation of Norwegian Enterprise (NHO)
Chair: Torbjørn Røe Isaksen, Editor E24
Photo Almlid: Moment Studio
Photo Torbjørn Røe Isaksen: Hallgeir Vågenes, VG
14:10–14:40 Break
14:40-15:35 Interaction between research, industry and authorities
Keynotes by
-
Anna-Lena Engwall, Country President Nordic, AstraZeneca
-
Cathrine Lofthus, Secretary General, Ministry of Health and Care Services
Panel discussion with additional participants
-
Alexandra Bech Gjørv, President and CEO, SINTEF
-
Jenni Nordborg, Director International Affairs, Lif – the research-based pharmaceutical companies
-
Jan Terje Andersen, Professor, Department of Pharmacology, UiO and Group leader Oslo University Hospital
Chair: Torbjørn Røe Isaksen, Editor E24
Photo: Alexandra Bech Gjørv:Terje Trobe/SINTEF. Torbjørn Røe Isaksen: Hallgeir Vågenes, VG
15:35-16:25 Convergence between medicine and technology
Key notes by
- Max Wegner, Senior Vice President, Head of Regulatory Affairs, Bayer
- Jon Jahren, Director Azure Cloud & AI, Microsoft Norway
Panel discussion with additional participants
- Per Morten Sandset, Vice-Rector for Research and Innovation, UiO
- Bjørn Atle Bjørnbeth, CEO, Oslo University Hospital
- Arnoldo Frigessi, Professor, Department of Biostatistics, UiO
Chair: Torbjørn Røe Isaksen, Editor E24
Photo: Torbjørn Røe Isaksen Hallgeir Vågenes, VG
17:00-19:00 Reception Oslo City Hall
The doors open at 17:00. The event starts at 17:30.